Beatus Pharmaceuticals Private Limited
About Beatus Pharmaceuticals Private Limited
Data last updated:
Beatus Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 09 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85191UP2015PTC071270. Its GSTIN is 09AAGCB3864N1Z4 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Manpreet Kaur and Jasbir Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 50 – A Adarsh Nagar Near Tehri Pulia Alambagh, Lucknow, Uttar Pradesh, India – 226005.
As per the financials filed for FY 2025, the company reported a revenue of ₹34,982, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹7,837 (net margin 22.4%) and EBITDA of ₹12,582 (EBITDA margin 36%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Beatus Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address50 – A Adarsh Nagar Near Tehri Pulia Alambagh, Lucknow, Uttar Pradesh, India – 226005
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Beatus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Beatus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Beatus Pharmaceuticals Private Limited
FY 2025 filings availableBeatus Pharmaceuticals Private Limited reported revenue of ₹34,982 (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over three years, including 19% growth in the latest year. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12,582 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,837 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 36% | ||||
| Net Profit Margin | 22.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Beatus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Beatus Pharmaceuticals Private Limited
Beatus Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manpreet Kaur | Director | 09 Jun 2015 | 11 Years 4 Months | Current |
| Jasbir Singh | Director | 09 Jun 2015 | 11 Years 4 Months | Current |
Peer comparison
Beatus Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Novexia Pharma Private Limited | ₹35,470 (FY 2024) | -98.0% | New Delhi, Delhi, India | |||
| RPS Healthcare Private Limited | ₹35,184 (FY 2020) | -99.0% | Bangalore, Karnataka, India | |||
| Beatus Pharmaceuticals Private Limitedthis company | ₹34,982 (FY 2025) | ₹7,837 | 22.4% | 19.0% | Lucknow, Uttar Pradesh, India | |
| MPDB Pharmaceuticals Private Limited | ₹34,545 (FY 2022) | -85.0% | Moradabad, Uttar Pradesh, India |
To see the full peer comparison of Beatus Pharmaceuticals Private Limited, buy the company report.
Auditor
Beatus Pharmaceuticals Private Limited is audited by BHATTACHARYA & MEHROTRA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHATTACHARYA & MEHROTRA | FY 2017 | 094339 |
Shareholding
The shareholding of Beatus Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Beatus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Beatus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Beatus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Beatus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCB3864N1Z4 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Beatus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Beatus Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Gulshan Kumar Kathuria ceased to be Director on 01 Aug 2016.
Frequently asked questions
Beatus Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in retail trading, within the trading industry. It was incorporated on 09 June 2015 (11+ years old) and is registered under CIN U85191UP2015PTC071270.
Beatus Pharmaceuticals has 2 current directors:
- Manpreet Kaur - Director
- Jasbir Singh - Director
The latest financial statements of Beatus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Beatus Pharmaceuticals is 09AAGCB3864N1Z4, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Beatus Pharmaceuticals is U85191UP2015PTC071270. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Beatus Pharmaceuticals was incorporated on 09 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Beatus Pharmaceuticals by revenue are Novexia Pharma Private Limited, RPS Healthcare Private Limited, MPDB Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Gulshan Kumar Kathuria ceased to be Director on 01 Aug 2016. Dheeraj Chhabra ceased to be Director on 02 Dec 2015. Jasbir Singh ceased to be Director on 08 Nov 2015. Beatus Pharmaceuticals has 5 board changes on record in total.
The registered office of Beatus Pharmaceuticals is at 50 – A Adarsh Nagar Near Tehri Pulia Alambagh, Lucknow, Uttar Pradesh, India – 226005.
Beatus Pharmaceuticals operates in the trading industry, in the retail trading segment.
The compliance status of Beatus Pharmaceuticals is compliant as of 10 September 2026. The company is actively filing with the Registrar of Companies.